tiprankstipranks
Trending News
More News >
Ugro Capital Limited (IN:UGROCAP)
:UGROCAP
India Market

Ugro Capital Limited (UGROCAP) AI Stock Analysis

Compare
6 Followers

Top Page

IN:UGROCAP

Ugro Capital Limited

(UGROCAP)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 4o)
Rating:53Neutral
Price Target:
₹188.00
▲(9.94% Upside)
Ugro Capital Limited's overall stock score is primarily influenced by its financial performance, which shows strong gross margins but significant challenges in revenue growth and cash flow management. The technical analysis indicates a positive trend, but with potential bearish momentum. The valuation suggests the stock is reasonably priced. The absence of earnings call and corporate events data means these components do not impact the score.
Positive Factors
Business Model Strength
The fintech-driven model enhances efficiency and customer experience, providing a competitive edge in the SME lending market.
Revenue Streams
Diverse revenue streams from interest and fees provide stable income, supporting financial resilience and growth potential.
Market Position
Targeting underserved SMEs positions Ugro Capital to capture market share in a growing sector, driving long-term growth.
Negative Factors
High Leverage
High leverage increases financial risk, potentially impacting the company's ability to manage debt and finance future growth.
Revenue Growth Challenges
Declining revenue growth indicates potential difficulties in expanding market reach and sustaining business operations.
Cash Flow Issues
Negative cash flows suggest liquidity issues, limiting the company's ability to invest in growth and manage financial obligations.

Ugro Capital Limited (UGROCAP) vs. iShares MSCI India ETF (INDA)

Ugro Capital Limited Business Overview & Revenue Model

Company DescriptionUgro Capital Limited (UGROCAP) is a financial services company based in India that focuses on providing tailored lending solutions to small and medium-sized enterprises (SMEs) across various sectors. The company leverages technology and data analytics to offer a range of products, including term loans, working capital loans, and other financial services designed to meet the unique needs of its clients, thereby fostering growth and expansion in the SME segment.
How the Company Makes MoneyUgro Capital generates revenue primarily through interest income earned on the loans it disburses to SMEs. The company's revenue model is based on a combination of interest rates charged on loans, processing fees, and other service fees associated with its lending products. Key revenue streams include the issuance of term loans and working capital loans, where Ugro Capital typically charges a competitive interest rate that reflects the risk profile of the borrower. Additionally, the company may earn income from partnerships with fintech platforms and other financial institutions that facilitate loan origination and customer acquisition. Factors contributing to Ugro Capital's earnings include its data-driven approach to credit assessment, which allows for efficient risk management and competitive pricing, as well as a growing market demand for SME financing solutions in India.

Ugro Capital Limited Financial Statement Overview

Summary
Ugro Capital Limited's financial performance is mixed. The income statement shows strong gross margins but declining revenue growth, which is concerning. The balance sheet indicates high leverage, posing financial risks, while profitability metrics are moderate. Cash flow analysis reveals significant challenges with negative cash flows, highlighting potential liquidity issues.
Income Statement
45
Neutral
Ugro Capital Limited's income statement shows a mixed performance. The company has a high gross profit margin of 100% in the latest year, indicating strong revenue retention. However, the net profit margin is moderate at 22.45%, and the EBIT and EBITDA margins are unusually high due to the nature of financial services, which may not accurately reflect operational efficiency. The revenue growth rate is concerning, with a significant decline of 48.36% in the latest year, indicating potential challenges in revenue generation.
Balance Sheet
50
Neutral
The balance sheet reveals a high debt-to-equity ratio of 3.37, suggesting significant leverage and potential financial risk. Return on equity is relatively low at 7.03%, indicating modest profitability relative to shareholder equity. The equity ratio stands at 22.32%, showing a moderate level of equity financing compared to total assets. Overall, the balance sheet indicates a leveraged position with moderate returns.
Cash Flow
30
Negative
Cash flow analysis highlights significant challenges, with negative operating and free cash flows. The free cash flow growth rate is negative, indicating deteriorating cash generation capabilities. The operating cash flow to net income ratio is negative, suggesting cash flow issues relative to reported earnings. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow is just covering net income, but the overall cash flow position is weak.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue10.45B9.64B7.07B4.88B2.68B1.33B
Gross Profit1.34B1.29B995.24M678.77M624.11M492.22M
EBITDA2.46B2.62B2.19B1.07B348.23M257.76M
Net Income1.48B1.44B1.19B397.76M145.51M287.27M
Balance Sheet
Total Assets0.0091.68B62.80B43.06B28.54B17.51B
Cash, Cash Equivalents and Short-Term Investments0.005.53B883.64M2.12B1.60B3.53B
Total Debt0.0069.04B46.53B31.49B18.31B7.88B
Total Liabilities-20.46B71.22B48.42B33.22B18.88B7.98B
Stockholders Equity20.46B20.46B14.38B9.84B9.67B9.52B
Cash Flow
Free Cash Flow0.00-25.00B-15.38B-12.61B-11.46B-3.59B
Operating Cash Flow0.00-24.74B-15.35B-12.20B-11.32B-3.47B
Investing Cash Flow0.00-799.24M-2.30B-845.42M413.80M-459.17M
Financing Cash Flow0.0026.55B18.14B12.79B10.23B5.08B

Ugro Capital Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price171.00
Price Trends
50DMA
177.14
Negative
100DMA
174.19
Negative
200DMA
173.33
Negative
Market Momentum
MACD
-1.47
Positive
RSI
45.07
Neutral
STOCH
34.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UGROCAP, the sentiment is Negative. The current price of 171 is below the 20-day moving average (MA) of 173.82, below the 50-day MA of 177.14, and below the 200-day MA of 173.33, indicating a bearish trend. The MACD of -1.47 indicates Positive momentum. The RSI at 45.07 is Neutral, neither overbought nor oversold. The STOCH value of 34.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:UGROCAP.

Ugro Capital Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹15.68B-1,420.68-6.03%-100.77%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
58
Neutral
₹32.40B29.730.90%5.73%12.29%
53
Neutral
₹20.56B11.3933.99%11.65%
51
Neutral
₹32.97B-10.17%-181.71%
48
Neutral
₹21.54B-1.23-45.13%-1646.01%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:UGROCAP
Ugro Capital Limited
171.65
-62.40
-26.66%
IN:ARMANFIN
Arman Financial Services Limited
1,476.85
148.85
11.21%
IN:BFINVEST
BF Investment Limited
408.80
-322.10
-44.07%
IN:MUTHOOTMF
Muthoot Microfin Ltd
175.05
-14.50
-7.65%
IN:SPANDANA
Spandana Sphoorty Financial Ltd.
270.85
-83.16
-23.49%
IN:TFCILTD
Tourism Finance Corporation of India Limited
66.40
30.08
82.82%

Ugro Capital Limited Corporate Events

Ugro Capital Converts Debentures to Equity Shares, Expands Capital Base
Dec 5, 2025

Ugro Capital Limited has announced the conversion of its compulsorily convertible debentures (CCDs) into equity shares, following the expiration of the 18-month tenure of the CCDs issued in June 2024. This conversion has resulted in the issuance of 7,342,732 new equity shares, increasing the company’s total equity share capital. The conversion aligns with the company’s strategic capital raise plan, while the unexercised warrants from the same issuance have lapsed, impacting the company’s financial structuring and market positioning.

UGRO Capital Converts Debentures to Equity Shares, Boosting Capital
Dec 5, 2025

UGRO Capital Limited has announced the conversion of its Compulsorily Convertible Debentures (CCDs) into equity shares, following the expiration of their 18-month tenure. This conversion increases the company’s equity share capital, reflecting a strategic move to strengthen its financial structure and market position. The conversion of 7,342,732 equity shares will align with existing shares, while unexercised warrants will lapse, impacting the company’s capital dynamics.

UGRO Capital Releases Q3 2025 Monitoring Report on Capital Utilization
Nov 14, 2025

UGRO Capital Limited has released a Monitoring Agency Report for the quarter ended September 30, 2025, detailing the utilization of proceeds from its preferential and rights issues. The report, prepared by India Ratings & Research Private Limited, complies with SEBI regulations and highlights the company’s adherence to capital utilization guidelines, potentially impacting its financial transparency and stakeholder confidence.

UGRO Capital Boosts Equity with CCD Conversion
Oct 28, 2025

UGRO Capital Limited has announced the allotment of equity shares following the conversion of Compulsorily Convertible Debentures (CCDs), raising INR 534.64 crores. This conversion increases the company’s equity share capital, indicating a strategic move to strengthen its financial position and enhance shareholder value.

Ugro Capital Limited Announces Allotment of Commercial Papers
Oct 10, 2025

Ugro Capital Limited announced the allotment of listed Commercial Papers, approved by its Investment and Borrowing Committee. This move, involving securities with a face value of Rs. 5,00,000 each, is part of the company’s strategy to enhance its financial offerings and strengthen its market position. The commercial papers are set to be redeemed on 17th March 2026, with an issue value of Rs. 14,45,25,900 and a redemption value of Rs. 15,00,00,000, indicating a strategic financial maneuver to optimize returns and liquidity.

Ugro Capital Announces INR 300 Crore NCD Issuance
Oct 8, 2025

Ugro Capital Limited has announced the issuance of up to 300,000 non-convertible debentures (NCDs) on a private placement basis, with a face value of INR 10,000 each, totaling INR 300 crore. This strategic move, approved by the company’s Investment and Borrowing Committee, includes a green shoe option to retain oversubscription of up to 150,000 additional NCDs, potentially raising an additional INR 150 crore. The issuance is part of Ugro Capital’s efforts to strengthen its financial position and expand its credit offerings, impacting its market presence and providing opportunities for investors.

Ugro Capital Announces Trading Window Closure
Sep 26, 2025

Ugro Capital Limited has announced the closure of its trading window in compliance with SEBI’s Prohibition of Insider Trading Regulations, 2015. This closure will be in effect from September 29, 2025, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2025. This measure is part of the company’s Code of Conduct for Prohibition of Insider Trading, impacting directors, specified persons, and their immediate relatives, ensuring compliance and transparency in financial reporting.

UGRO Capital Secures RBI Approval for Profectus Acquisition
Sep 18, 2025

UGRO Capital Limited has received approval from the Reserve Bank of India for its proposed acquisition of Profectus Capital Private Limited, with the transaction expected to close by October 31, 2025. Additionally, the company has adjusted the terms of its Compulsorily Convertible Debentures to facilitate the acquisition, ensuring the coupon is paid immediately post-allotment.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025